AI-assisted, human-published
04/03/2024 /M & A
ProMed Pharma Expands Portfolio Through Acquisition of SpineThera's Assets
ProMed Pharma acquires SpineThera’s manufacturing assets and intellectual property option, while SpineThera maintains focus on innovative injectable drugs.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com